Your browser doesn't support javascript.
loading
Immune changes over time and survival in patients with cirrhosis treated with non-selective beta-blockers: A prospective longitudinal study.
Almenara, Susana; Lozano-Ruiz, Beatriz; Herrera, Ivan; Gimenez, Paula; Miralles, Cayetano; Bellot, Pablo; Rodriguez, Maria; Palazon, Jose M; Tarín, Fabián; Sarmiento, Héctor; Francés, Rubén; Gonzalez-Navajas, Jose Manuel; Pascual, Sonia; Zapater, Pedro.
Afiliação
  • Almenara S; CIBERehd, Health Institute Carlos III, Madrid, Spain; Clinical Pharmacology Unit. Alicante General University Hospital, Alicante, Spain; Institute of Research, Development, and Innovation in Healthcare Biotechnology of Elche (IDiBE), University Miguel Hernández de Elche, Spain; Alicante Institute fo
  • Lozano-Ruiz B; CIBERehd, Health Institute Carlos III, Madrid, Spain; Institute of Research, Development, and Innovation in Healthcare Biotechnology of Elche (IDiBE), University Miguel Hernández de Elche, Spain.
  • Herrera I; Liver Unit. Alicante General University Hospital, Alicante, Spain.
  • Gimenez P; CIBERehd, Health Institute Carlos III, Madrid, Spain.
  • Miralles C; Liver Unit. Alicante General University Hospital, Alicante, Spain.
  • Bellot P; Liver Unit. Alicante General University Hospital, Alicante, Spain.
  • Rodriguez M; Liver Unit. Alicante General University Hospital, Alicante, Spain.
  • Palazon JM; Liver Unit. Alicante General University Hospital, Alicante, Spain.
  • Tarín F; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain; Hematology Department. Alicante General University Hospital, Alicante, Spain.
  • Sarmiento H; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain; Hematology Department. Alicante General University Hospital, Alicante, Spain.
  • Francés R; CIBERehd, Health Institute Carlos III, Madrid, Spain; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain; Clinical Medicine Department, University Miguel Hernández de Elche, Alicante, Spain.
  • Gonzalez-Navajas JM; CIBERehd, Health Institute Carlos III, Madrid, Spain; Institute of Research, Development, and Innovation in Healthcare Biotechnology of Elche (IDiBE), University Miguel Hernández de Elche, Spain; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • Pascual S; CIBERehd, Health Institute Carlos III, Madrid, Spain; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain; Liver Unit. Alicante General University Hospital, Alicante, Spain.
  • Zapater P; CIBERehd, Health Institute Carlos III, Madrid, Spain; Clinical Pharmacology Unit. Alicante General University Hospital, Alicante, Spain; Institute of Research, Development, and Innovation in Healthcare Biotechnology of Elche (IDiBE), University Miguel Hernández de Elche, Spain; Alicante Institute fo
Biomed Pharmacother ; 163: 114885, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37201262
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article